We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New power to temporarily control potentially harmful new drugs comes into effect, along with an importation ban on two further substances.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Letters were sent about Xeljanz▼ (tofacitinib), ranitidine, Nulojix (belatacept), fluoroquinolone antibiotics, Genvoya▼, Stribild▼, Tybost, and belimumab (Benlysta▼). Drug alerts were issued about Accord losartan potassium containing products and Ozurdex implants.
Men who inject anabolic steroids and tanning drugs are at higher risk of HIV and viral hepatitis.
Advice on the classification of 24 steroidal and two non-steroidalsubstances,
In March 2016, letters were sent regarding SGLT2 inhibitors, insulin lispro, natalizumab, noradrenaline, radium-223 dichloride, aflibercept and idelalisib.
Nearly 500 people have been arrested since the government’s landmark Psychoactive Substances Act came into force 6 months ago.
First published during the 2016 to 2019 May Conservative government
State-of-the-art medicines will be fast-tracked to patients thanks to the Early Access to Medicines Scheme.
A change to the Misuse of Drugs Act 1971.
Statins (HMG-CoA reductase inhibitors) are widely used medicines for patients with lipid disorders and in the primary and secondary prevention of heart attack and stroke.
Sildenafil is not authorised for use in pregnancy for the treatment of intrauterine growth restriction. The STRIDER clinical trial, which was studying the use of sildenafil in pregnancy for intrauterine growth restriction, has been prematurely discontinued due to a higher...
New guidance on contraceptive methods and frequency of pregnancy testing to reduce inadvertent exposures during pregnancy in a woman taking a medicine of teratogenic potential.
The Government responds to the ACMD’s further advice on synthetic cannabinoids and advice on methoxetamine and related compounds.
In June 2016, a letter was sent to healthcare professionals about Thalidomide Celgene.
Twelve month bans on suspected substances will help the government react quickly to the changing drugs market says James Brokenshire.
MHRA highlight the pitfalls of buying medicines online to students
Risk of psychological and behavioural side effects.
Expert body recommends strengthened laws on anabolic steroids following concerns about the number of users in the UK.
MHRA urges people to be cautious whilst an Olympic review of the sports supplements industry highlights improvements
Music event organisers were today asked to be vigilant about the sale of 'legal highs'.
This circular draws attention to a change to the Misuse of Drugs Act 1971.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).